 Shares of Alexion Pharmaceuticals NASDAQ:ALXN moved higher by 2.2 in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 9.32 year over year to 3.52, which beat the estimate of 3.16. 